on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology
The Vanguard Group, Inc. has released its Form 8.3, detailing its dealings in Mural Oncology plc. As per the disclosure, Vanguard holds 771,443 ordinary shares, representing a 4.47% interest in Mural Oncology. The position disclosure date is August 29, 2025.
The filing follows the rules set by the Irish Takeover Panel Act, 1997 and the Takeover Rules, 2022. The document reveals that no other positions, cash-settled, or stock-settled derivatives currently exist regarding Mural Oncology. Furthermore, Vanguard reported a minor transaction involving the sale of 16 ordinary shares at $2.06 each.
There are no indemnity arrangements or agreements relating to options or derivatives. The disclosure also confirms no additional Supplemental Form 8 is attached.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news